Name: iBio, Inc. (IBIO) Financial Statements
Creator: FinSpry

iBio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

iBio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021
Revenue & Gross Profit
Revenue	0.40	0.23	0.00	1.88	2.37
Cost of Revenue	0.00	0.00	4.92	0.22	1.46
Gross Profit	0.40	0.23	-4.92	2.17	0.91
Operating Expenses
Research & Development	8.31	5.19	10.33	9.83	9.99
Selling, General & Administrative	10.69	11.67	19.02	21.75	21.89
Operating Expenses	19.00	16.86	29.34	31.58	31.88
Operating Income	-18.60	-16.63	-29.34	-29.70	-30.97
Other Income/Expense
Interest Income	0.44	0.36	0.21	0.18	0.14
Interest Expense	0.21	-0.17	0.08	0.00	-2.45
Other Income/Expense	0.23	-1.00	-0.10	0.01	0.01
Income
Income Before Tax	-18.38	-15.27	-29.31	-29.51	-23.21
Income Tax Expense	0.00	-5.30	-12.79	-9.05	-0.06
Net Income	-18.38	-24.91	-65.01	-50.39	-23.21
Net Income - Continuous Operations	-18.38	-15.44	-29.31	-29.51	0.00
Net Income - Discontinued Operations	0.00	-9.46	-35.70	-20.79	0.00
EBITDA	-17.04	5.54	-27.85	-25.72	-28.55
EBIT	-18.60	4.17	-29.23	-29.51	-30.97
Depreciation & Amortization	1.13	0.64	1.38	3.79	2.41
Earnings Per Share
Basic EPS	-2.00	-13.00	-106.00	-116.00	-60.00
Diluted EPS	-2.00	-13.00	-106.00	-116.00	-60.00
Basic Shares Outstanding	10.50	3.83	0.61	0.44	0.39
Diluted Shares Outstanding	10.50	3.83	0.61	0.44	0.39